Clarivate Plc (NYSE:CLVT) Q2 2024 Earnings Conference Call August 6, 2024 9:00 AM ET Company Participants Mark Donohue - Vice President of Investor Relations Andrew Snyder - Chairman of the Board Jonathan Gear - Chief Executive Officer, Matti Shem Tov - Jonathan Collins - Chief Financial Officer Conference Call Participants Toni Kaplan - Morgan Stanley Manav Patnaik - Barclays Surinder Thind - Jefferies Shlomo Rosenbaum - Stifel Wahid Amin - Bank of America Owen Lau - Oppenheimer Andrew Nicholas - William ...

Clarivate PLC (CLVT) reported $650.3 million in revenue for the quarter ended June 2024, representing a yearover-year decline of 2.8%. EPS of $0.20 for the same period compares to $0.21 a year ago. The reported revenue represents a surprise of -0.46% over the Zacks Consensus Estimate of $653.29 million. With the consensus EPS estimate being $0.18, the EPS surprise was +11.11%. While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Str ...

Clarivate PLC (CLVT) came out with quarterly earnings of $0.20 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.21 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 11.11%. A quarter ago, it was expected that this company would post earnings of $0.14 per share when it actually produced earnings of $0.14, delivering no surprise. Over the last four quarters, the company has surpa ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Ordinary Shares, no par value CLVT New York Stock Exchange Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _______ Commission Fi ...

Clarivate Reports Second Quarter 2024 Results — Reaffirms 2024 Outlook — London, UK -- August 6, 2024 Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights • Revenues of $650.3 million decreased 2.8% • Organic revenues decreased 0.6%, as an increase in subscription revenues of 0.7% was offset by a decrease in reoccurring revenues of 0.7% a ...

Chief Executive Jonathan Gear to Step Down as CEO and Member of the Board LONDON, Aug. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced that the Board has appointed Matti Shem Tov, former CEO of ProQuest, as the Company's next CEO, effective August 9, 2024. Mr. Shem Tov will also join the Company's Board of Directors. Jonathan Gear, Chief Executive Officer, will step down as CEO and as a member of the Board at that time, and will t ...

— Reaffirms 2024 Outlook — LONDON, Aug. 6, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the second quarter ended June 30, 2024. Second Quarter 2024 Financial Highlights Revenues of $650.3 million decreased 2.8% Organic revenues decreased 0.6%, as an increase in subscription revenues of 0.7% was offset by a decrease in re-occurring revenues of 0.7% and transactional and other revenues of 4. ...

Empowering biopharma with enhanced safety insights to anticipate risks and unlock new competitive advantages The new platform features an upgraded technology stack and enhanced functionality while retaining its core capabilities. These improvements include an 80% reduction in loading times for targets, drugs, drug combinations and adverse events. The platform now offers faster search capabilities, a clearer visual design, full-screen visualization and additional analytic tools. OFF-X empowers users to monit ...

LONDON, July 24, 2024 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Richard Roedel will retire from the Board of Directors (the "Board") for health reasons, effective December 31, 2024. The Board expects Valeria Alberola, a member of the Board since May 2021, and a member of its Audit and Finance Committees, to succeed Mr. Roedel as Chair of the Audit Committee. Ms. Alberola brings over 25 years of global experience in corporate fi ...

Board Changes - Richard Roedel will retire from the Board of Directors for health reasons, effective December 31, 2024 [1] - Valeria Alberola, a Board member since May 2021, is expected to succeed Mr Roedel as Chair of the Audit Committee [1] - Andy Snyder, Board Chair, expressed gratitude for Mr Roedel's leadership and dedication since 2020 and confidence in Ms Alberola's ability to lead the Audit Committee [2] Valeria Alberola's Background - Ms Alberola brings over 25 years of global experience in corporate finance, investment banking, sustainable investments, operations, and strategic management consulting [2] - She served as CEO of Zoma Holdings, LLC from January 2019 to March 2024, following her tenure as COO from 2017 to December 2018 [2] - Previously, she was CFO of Bridge Education Group, Inc and a partner at Q Advisors LLC, advising on M&A and debt and equity financings for technology and telecommunications clients [2] - Ms Alberola holds a B S in Economics and Business Administration from Pontificia Universidad Católica de Chile and an M B A from Kellogg School of Management at Northwestern University, where she was a Fulbright scholar [2] Company Overview - Clarivate Plc is a leading global provider of transformative intelligence, offering enriched data, insights & analytics, workflow solutions, and expert services in Academia & Government, Intellectual Property, and Life Sciences & Healthcare [4]